We are actually quite eager to update the ONCX ibox.
Need to update the share structure, new BOD appointments as well as outdated stickies.
Updates are planned in a few weeks after the next Q drop.
We also plan to include relevant information from the latest 10K dated 2018-03-14, which clearly discloses the number of subjects in the initial 2016 dosing and summary of results.
“…Our initial commercial focus is the development of Prolanta™ for the treatment of ovarian cancer. We have commenced a Phase 1 clinical trial after receiving clearance from the FDA. We completed the first dosing group of 3 subjects in the Phase I clinical trial, with no evidence of serious adverse events or dose-limiting toxicities. The recruitment of subjects for the next dosing group commenced in early 2018. Additional clinical studies will require additional supplies of Prolanta™ through production of new supplies by a contract manufacturer…”
That way, people don’t make incorrect statements like “...901 days in clinical trials without even a single worthless update...”
Apparently, if this information isnt spoon fed, included in the ibox and sourced for all to see, people cant locate it or make intelligent statements regarding its validity.
Hope to remedy that soon.
Thanks for your input and have a nice day.
GLTA, IMO and FWIW.
Market Data 
Markets 
AI
